Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan · Delayed Price · Currency is TWD 88.80
-3.50 (-3.79%)
Aug 19, 2026, 1:30 PM CST
Tien Liang BioTech Market Cap
Tien Liang BioTech has a market cap or net worth of 4.22 billion as of August 19, 2026. Its market cap has increased by 160.37% in one year.
Market Cap
4.22B
Enterprise Value
4.62B
Revenue
650.87M
Ranking
n/a
PE Ratio
61.19
Stock Price
88.80
ChartMarket Cap Chart
Since July 19, 2005, Tien Liang BioTech's market cap has increased from 767.70M to 4.22B, an increase of 450.17%. That is a compound annual growth rate of 8.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 4.22B | 197.74% |
| Dec 31, 2025 | 1.42B | -25.30% |
| Dec 31, 2024 | 1.90B | 186.21% |
| Dec 29, 2023 | 663.52M | -6.15% |
| Dec 30, 2022 | 706.99M | 4.39% |
| Dec 30, 2021 | 677.25M | 32.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 6.33B |
| Formosa Laboratories | 6.18B |
| Orient Pharma | 5.34B |
| Panion & Bf Biotech | 5.02B |
| Orient EuroPharma | 4.27B |
| LIWANLI Innovation | 3.92B |
| Easywell Biomedicals | 3.76B |
| Yoda Pharmaceuticals | 3.57B |